Latest Andrew K. Lee Stories
Renowned oncology leader, innovator, and researcher from MD Anderson joins DFW's first proton therapy treatment facility IRVING, Texas, Feb. 9, 2015 /PRNewswire/ -- Dr. Andrew K.
Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer.
By David Douglas NEW YORK (Reuters Health) - The time it takes for prostate-specific antigen (PSA) levels to double can help predict the clinical outcome of patients with prostate cancer who have been treated with combined radiation and hormone therapy, researchers report in the International Journal of Radiation Oncology, Biology, Physics.
- A person in a secondary role, specifically the second most important character (after the protagonist).